---
stable_id: R-HSA-9664991
display_name: RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2
  KD mutants
species: Homo sapiens
summary: For the following ERBB2 KD mutants that were shown to activate RAS/RAF/MAPK
  signaling, it is assumed that they, like phosphorylated heterodimers of the wild
  type ERBB2, bind to and phosphorylate SHC1, leading to recruitment of the GRB2:SOS1
  complex and activating guanyl-nucleotide exchange on RAS:<br><br>ERBB2 L755P (Kancha
  et al. 2011);<br>ERBB2 L755S (Trowe et al. 2008, Kancha et al. 2011, Bose et al.
  2013, Cocco et al. 2018);<br>ERBB2 I767M (Ng et al. 2015);<br>ERBB2 D769H (Bose
  et al. 2013);<br>ERBB2 V777L (Kancha et al. 2011, Bose et al. 2013);<br>ERBB2 G778_P780dup
  (Suzawa et al. 2016);<br>ERBB2 T798I (Hanker et al. 2017);<br>ERBB2 T798M (Kancha
  et al. 2011, Rexer et al. 2013);<br>ERBB2 V842I (Bose et al. 2013);<br>ERBB2 T862A
  (Kancha et al. 2011);<br>ERBB2 L869R (Hanker et al. 2017);<br>ERBB2 H878Y (Kancha
  et al. 2011, Hu, Hu et al. 2015, Hu, Wan et al. 2015);<br>ERBB2 R896C (Bose et al.
  2013);<br>ERBB2 L755_T759del (Bose et al. 2013);<br>ERBB2 G776S (Fan et al. 2008);<br>ERBB2
  Y772_A775dup (Wang et al. 2006);<br><br>Activation of RAS/RAF/MAPK signaling downstream
  of the following ERBB2 KD cancer mutants has not been studied and they are annotated
  as candidates:<br><br>ERBB2 L755M <br>ERBB2 L755W<br>ERBB2 D769Y<br>ERBB2 D769N<br>ERBB2
  V777M<br>ERBB2 V777E<br>ERBB2 T733I<br>ERBB2 V842E<br>ERBB2 L869Q<br>ERBB2 H878R<br>ERBB2
  R896H<br>ERBB2 G776C<br>ERBB2 G776L<br>ERBB2 G776V
---

# RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2 KD mutants
**Reactome ID:** [R-HSA-9664991](https://reactome.org/content/detail/R-HSA-9664991)
**Species:** Homo sapiens

## Summary

For the following ERBB2 KD mutants that were shown to activate RAS/RAF/MAPK signaling, it is assumed that they, like phosphorylated heterodimers of the wild type ERBB2, bind to and phosphorylate SHC1, leading to recruitment of the GRB2:SOS1 complex and activating guanyl-nucleotide exchange on RAS:<br><br>ERBB2 L755P (Kancha et al. 2011);<br>ERBB2 L755S (Trowe et al. 2008, Kancha et al. 2011, Bose et al. 2013, Cocco et al. 2018);<br>ERBB2 I767M (Ng et al. 2015);<br>ERBB2 D769H (Bose et al. 2013);<br>ERBB2 V777L (Kancha et al. 2011, Bose et al. 2013);<br>ERBB2 G778_P780dup (Suzawa et al. 2016);<br>ERBB2 T798I (Hanker et al. 2017);<br>ERBB2 T798M (Kancha et al. 2011, Rexer et al. 2013);<br>ERBB2 V842I (Bose et al. 2013);<br>ERBB2 T862A (Kancha et al. 2011);<br>ERBB2 L869R (Hanker et al. 2017);<br>ERBB2 H878Y (Kancha et al. 2011, Hu, Hu et al. 2015, Hu, Wan et al. 2015);<br>ERBB2 R896C (Bose et al. 2013);<br>ERBB2 L755_T759del (Bose et al. 2013);<br>ERBB2 G776S (Fan et al. 2008);<br>ERBB2 Y772_A775dup (Wang et al. 2006);<br><br>Activation of RAS/RAF/MAPK signaling downstream of the following ERBB2 KD cancer mutants has not been studied and they are annotated as candidates:<br><br>ERBB2 L755M <br>ERBB2 L755W<br>ERBB2 D769Y<br>ERBB2 D769N<br>ERBB2 V777M<br>ERBB2 V777E<br>ERBB2 T733I<br>ERBB2 V842E<br>ERBB2 L869Q<br>ERBB2 H878R<br>ERBB2 R896H<br>ERBB2 G776C<br>ERBB2 G776L<br>ERBB2 G776V
